Bionexus Gene Lab Corp (BGLC)

$2.28 -0.02 (-0.87%)
Market Cap 5.61M
Revenue (ttm) 7.42M
Net Income (ttm) -2.98M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -40.16%
Debt to Equity Ratio 0.00
Volume 2,642
Avg Vol 13,972
Day's Range N/A - N/A
Shares Out 2.42M
Stochastic %K 77%
Beta 4.09
Analysts Strong Buy
Price Target N/A

Company Profile

BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SH...

Industry: Specialty Chemicals
Sector: Basic Materials
Phone: 60 1 307 241 6898
Address:
Menara UOA Bangsar, Unit A-28-7, Level 28, Tower A No.5 Jln Bangsar Utama 1, Kuala Lumpur, Malaysia
focafoca99
focafoca99 May. 29 at 1:22 PM
$BGLC urged deeper Malaysia‑China biotech co‑development at the 2026 Economic Cooperation Outlook Forum.
0 · Reply
Barryman1
Barryman1 May. 29 at 1:14 PM
$DEVS Nice ! See below 👀 be early in $BGLC
0 · Reply
Barryman1
Barryman1 May. 29 at 1:11 PM
$BGLC lol am I the first in here? Only 4% up now Be early 😁
0 · Reply
Barryman1
Barryman1 May. 29 at 1:10 PM
$BGLC news! Bought Some With My $DEVS gains 😁
0 · Reply
Aburose
Aburose May. 27 at 11:28 PM
$BGLC let go
0 · Reply
Aburose
Aburose May. 27 at 11:25 PM
$BGLC over 3 it will go to 7-8
0 · Reply
Aburose
Aburose May. 27 at 11:21 PM
$BGLC possible hit 7
0 · Reply
Aburose
Aburose May. 27 at 11:20 PM
$BGLC let go like ATPC
0 · Reply
Aburose
Aburose May. 27 at 11:18 PM
$BGLC like ATBC
0 · Reply
Aburose
Aburose May. 27 at 11:10 PM
$BGLC 5+
0 · Reply
Latest News on BGLC
BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development

May 29, 2026, 9:00 AM EDT - 5 days ago

BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development

Bionexus Gene Lab appoints Muthu Meyyappan as CCO, Fidelion

2026-03-11T12:50:13.000Z - 3 months ago

Bionexus Gene Lab appoints Muthu Meyyappan as CCO, Fidelion

BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform

Mar 11, 2026, 8:45 AM EDT - 3 months ago

BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform

Bionexus Gene Lab appoints Matthew Barsing as Chairman

2026-02-23T13:49:39.000Z - 3 months ago

Bionexus Gene Lab appoints Matthew Barsing as Chairman

BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman

Feb 23, 2026, 8:30 AM EST - 3 months ago

BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman

Bionexus Gene Lab announces formal commencement of 2026 Deployment Phase

2026-01-28T14:10:28.000Z - 4 months ago

Bionexus Gene Lab announces formal commencement of 2026 Deployment Phase

BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN's Multi-Billion Dollar Market

Jan 28, 2026, 9:00 AM EST - 4 months ago

BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN's Multi-Billion Dollar Market

Bionexus Gene Lab completes investment in Fidelion Diagnostics

2025-12-03T13:50:27.000Z - 6 months ago

Bionexus Gene Lab completes investment in Fidelion Diagnostics

BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™

Dec 3, 2025, 8:45 AM EST - 6 months ago

BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™

Bionexus Gene Lab secures $500M equity facility from ARC Group

2025-12-02T13:26:36.000Z - 6 months ago

Bionexus Gene Lab secures $500M equity facility from ARC Group

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization

Dec 2, 2025, 8:05 AM EST - 6 months ago

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization

Bionexus Gene Lab, Fidelion Diagnostics execute license for VitaGuard platform

2025-12-01T13:26:30.000Z - 6 months ago

Bionexus Gene Lab, Fidelion Diagnostics execute license for VitaGuard platform

BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene

Dec 1, 2025, 8:00 AM EST - 6 months ago

BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene

Bionexus enters agreements with Fidelion Diagnostics, Tongshu Biotechnology

2025-11-12T13:25:12.000Z - 7 months ago

Bionexus enters agreements with Fidelion Diagnostics, Tongshu Biotechnology

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization

Nov 12, 2025, 8:00 AM EST - 7 months ago

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization

Bionexus Gene Lab files $100M shelf registration, establishes $20M ATM program

2025-11-10T13:20:29.000Z - 7 months ago

Bionexus Gene Lab files $100M shelf registration, establishes $20M ATM program

BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth Opportunities

Nov 10, 2025, 8:00 AM EST - 7 months ago

BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth Opportunities

Bionexus Gene Lab files $100M mixed securities shelf

2025-11-07T21:35:16.000Z - 7 months ago

Bionexus Gene Lab files $100M mixed securities shelf

Bionexus Gene Lab signs strategic partnership term sheet with BirchBioMed

2025-10-20T12:26:00.000Z - 8 months ago

Bionexus Gene Lab signs strategic partnership term sheet with BirchBioMed

BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.

Oct 20, 2025, 8:00 AM EDT - 8 months ago

BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.

Why Is BioNexus Gene Lab Stock (BGLC) Up 80% Today?

2025-07-31T01:28:00.000Z - 10 months ago

Why Is BioNexus Gene Lab Stock (BGLC) Up 80% Today?

Bionexus Gene Lab, Fidelion sign term sheet for partnership

2025-07-30T12:31:27.000Z - 11 months ago

Bionexus Gene Lab, Fidelion sign term sheet for partnership

BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance—Touted as a new “DeepSeek Moment” in Precision Oncology

Jul 30, 2025, 8:00 AM EDT - 11 months ago

BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance—Touted as a new “DeepSeek Moment” in Precision Oncology

BioNexus Gene Lab Corp trading resumes

2025-07-03T13:40:38.000Z - 11 months ago

BioNexus Gene Lab Corp trading resumes

BioNexus Gene Lab Corp trading halted, volatility trading pause

2025-07-03T13:35:14.000Z - 11 months ago

BioNexus Gene Lab Corp trading halted, volatility trading pause

Bionexus Gene Lab regains Nasdaq compliance

2025-04-30T15:30:24.000Z - 1 year ago

Bionexus Gene Lab regains Nasdaq compliance

BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness

Apr 30, 2025, 11:25 AM EDT - 1 year ago

BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness

BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory

Apr 15, 2025, 11:00 AM EDT - 1 year ago

BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory

BioNexus Gene Lab Corp trading halted, news pending

2025-04-04T23:55:18.000Z - 1 year ago

BioNexus Gene Lab Corp trading halted, news pending

Bionexus Gene Lab enters partnership with ML Tech

2025-03-07T16:10:52.000Z - 1 year ago

Bionexus Gene Lab enters partnership with ML Tech

BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy

Mar 7, 2025, 11:00 AM EST - 1 year ago

BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy

Bionexus Gene Lab announces board approval of Ethereum treasury strategy

2025-03-05T16:11:02.000Z - 1 year ago

Bionexus Gene Lab announces board approval of Ethereum treasury strategy

BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper

Mar 5, 2025, 11:00 AM EST - 1 year ago

BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper

BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.

Sep 25, 2024, 11:31 AM EDT - 1 year ago

BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.

BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.

Sep 13, 2024, 12:05 PM EDT - 1 year ago

BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.

BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions

Sep 12, 2024, 1:23 PM EDT - 1 year ago

BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions

BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production

Sep 11, 2024, 11:05 AM EDT - 1 year ago

BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production

BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd

Aug 27, 2024, 11:35 AM EDT - 1 year ago

BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd

BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd

Aug 26, 2024, 12:15 PM EDT - 1 year ago

BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd

BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare

Apr 18, 2024, 2:52 PM EDT - 2 years ago

BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare

BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market

Jul 24, 2023, 11:30 AM EDT - 3 years ago

BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market

BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market

Jul 20, 2023, 1:29 PM EDT - 3 years ago

BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market

focafoca99
focafoca99 May. 29 at 1:22 PM
$BGLC urged deeper Malaysia‑China biotech co‑development at the 2026 Economic Cooperation Outlook Forum.
0 · Reply
Barryman1
Barryman1 May. 29 at 1:14 PM
$DEVS Nice ! See below 👀 be early in $BGLC
0 · Reply
Barryman1
Barryman1 May. 29 at 1:11 PM
$BGLC lol am I the first in here? Only 4% up now Be early 😁
0 · Reply
Barryman1
Barryman1 May. 29 at 1:10 PM
$BGLC news! Bought Some With My $DEVS gains 😁
0 · Reply
Aburose
Aburose May. 27 at 11:28 PM
$BGLC let go
0 · Reply
Aburose
Aburose May. 27 at 11:25 PM
$BGLC over 3 it will go to 7-8
0 · Reply
Aburose
Aburose May. 27 at 11:21 PM
$BGLC possible hit 7
0 · Reply
Aburose
Aburose May. 27 at 11:20 PM
$BGLC let go like ATPC
0 · Reply
Aburose
Aburose May. 27 at 11:18 PM
$BGLC like ATBC
0 · Reply
Aburose
Aburose May. 27 at 11:10 PM
$BGLC 5+
0 · Reply
Rasto2020
Rasto2020 May. 27 at 8:40 PM
$BGLC hmm
1 · Reply
Rasto2020
Rasto2020 May. 26 at 7:44 PM
$BGLC last year it was a win .,, This year it could become a sympathy play to YMAT
1 · Reply
SuperGreenToday
SuperGreenToday May. 14 at 3:10 PM
$BGLC
0 · Reply
TheBigSauce
TheBigSauce May. 13 at 9:40 PM
$BGLC $DXF $NWGL $YJ DXF baby! Another China rally?! NWGL next imo. GLTA!
0 · Reply
Steeda1974
Steeda1974 Apr. 17 at 6:21 PM
$DXF $NWGL $YJ $BGLC
0 · Reply
TheBigSauce
TheBigSauce Apr. 17 at 10:37 AM
$DXF Always one to watch when China heats up $NWGL 🇨🇳 Hard to ignore. Low float, oversold with huge upside $YJ and $BGLC two more for watch list Commentary | China is coming back – and the timing couldn’t be better - https://www.reuters.com/world/china/china-is-coming-back-timing-couldnt-be-better-2026-04-16/
0 · Reply
TheBigSauce
TheBigSauce Apr. 16 at 7:16 PM
$ATXG 🇨🇳 Good news from China. I’m in here for big move. Nice momentum. $NWGL 👀Overlooked and oversold. This one is going to explode soon $BGLC $RETO $RYOJ All worth a look if we see another China rally https://www.bbc.com/news/articles/c4gxjpekk19o
1 · Reply
TheBigSauce
TheBigSauce Apr. 2 at 12:25 AM
$AEHL The trolls seem worried. On squeeze watch. I’ve added more $GRDX and $GURE Nice moves today. Still holding some $YJ waking up and $BGLC on my wl.
0 · Reply
TheBigSauce
TheBigSauce Mar. 27 at 11:20 AM
$AEHL $BGLC $NWGL $RETO $VMAR NWGL 👀Volume. Ready for big bounce AEHL I’ll be on bid again
0 · Reply
TheBigSauce
TheBigSauce Mar. 26 at 8:14 PM
$AEHL 🚨📈 Short cover time? Reminds me of $TIRXF $LGHL and $BGLC before their big runs
0 · Reply